INTRODUCTION AND OBJECTIVES: After radical cystoprostatectomy (RC), post-operative erectile dysfunction can have a significant impact on a patient's quality-of-life. Inflatable penile prosthesis (IPP) offers patients a definitive treatment option when refractory to medical therapies. To date, there is no series describing the outcomes of three-piece IPP in patients with urinary diversions. Due to the obliteration of the space of Retzius and hostile anatomy of these patients a careful surgical approach is necessary for successful outcomes. We present a description of our technique in placing a three-piece IPP for post-operative erectile dysfunction in patients with a history of RC with orthotopic neobladder (NB), ileal conduit, or continent cutaneous diversion (CCD).
METHODS: From 2007 -2016, using an IRB-approved database we completed a retrospective review of patients who underwent primary placement of an IPP. We identified 61 patients (54 NB, 4 ileal conduit, 3 CCD) with urinary diversion who underwent subsequent placement of a three-piece IPP (AMS 700CXM, American Medical Systems Inc, Minnetonka, MN, USA). All 61 patients underwent RC in their treatment of carcinoma (55 bladder, 6 prostate). The device was implanted via an infrapubic approach and the reservoir placed in the lateral retroperitoneal space via a separate incision two finger-breadths medial to the anterior superior iliac spine. Patient demographics and postoperative outcomes including prosthetic infection were examined and statistical analysis was performed.
RESULTS: There were no high-grade intraoperative complications. Median follow-up was 16.8 months (2-76 months). Three patients (4.9%) developed an infection of their prosthesis that required explantation. Two of those patients underwent successful IPP reimplantation. 5 patients (8.1%) required revision surgery (4 pump relocations, 1 corporal aneurysm repair). We did not find statistically significant associations between infection and comorbidities, age, exposure to chemotherapy, or type of urinary diversion.
CONCLUSIONS: Despite advances in neurovascular sparing techniques, sexual dissatisfaction is common in patients after RC. Patients are often refractory to medical therapy. The IPP offers patients a definitive treatment option and excellent patient and partner satisfaction. In the hands of experienced surgeons, the three-piece IPP can be placed successfully in patients with all form of urinary diversion.
Source of Funding: None

MP25-09 USE OF 3D PRINTING TO PROTOTYPE A CUSTOM SHAPE MEMORY ALLOY PENILE PROSTHESIS
Brian Le*, Madison, WI; Kevin McVary, Alberto Colombo, Springfield, IL INTRODUCTION AND OBJECTIVES: Three-dimensional (3D) printing or additive printing is a new technology that allows for construction of complex shapes and designs outside the constraints of traditional manufacturing techniques. Traditional 3D printing was limited to thermosensitive plastics that have limited medical applications. Herein, we describe the application of a novel process that allows for 3D printing of shape memory alloys (SMA). Using our previously described concept of a SMA penile prosthesis for the treatment of erectile dysfunction, we sought to construct an intracavernosal cylinder using 3D printing technology.
METHODS: A computer-aided design (Solidworks) 3D construct of the exoskeleton for our SMA penile prosthesis was fed into a computer-controlled 3D Bio Plotter (EnvisionTec, Germany). A novel custom printing ink consisting of pre-alloyed nickel-titanium (Ni-Ti) powder suspended in a Poly Lactic-co-Glycolic Acid (PLGA) and trisolvent mixture was serially added in a precise 3D pattern to produce a green body reflecting the CAD geometry. Subsequently, the green body was sintered at a temperature of 1200 C, just 20-30 C below the melting point of NiTi, for 5 hours to produce the final product. This was then evaluated for its mechanical properties compared to our Ni-Ti extruded tube.
RESULTS: A 1:4 scale version of the exoskeleton of our novel SMA penile prosthesis was constructed using 3D printing technology from Ni-Ti powder suspended in a PLGA/solvent mixture. Total printing time was 20 minutes (figure 1). After sintering, there was a~30% volume reduction, which was homogenous in 3 directions. Mechanical properties were evaluated and found to be comparable to non-3D printed prototypes and SMA properties maintained.
CONCLUSIONS: 3D printing is a viable option for construction of SMA devices, including penile prostheses. The 3D-printed SMA prototype maintained its unique biomechanical properties. This technology opens up the possibility of more complex structures and customization without the constraints of traditional manufacturing techniques.
Source of Funding: Partial Funding through Boston Scientific
MP25-10 CHARACTERISTICS AND INFECTION RISK IN PATIENTS UNDERGOING MULTIPLE INFLATABLE PENILE PROSTHESES
Brian Montgomery*, Matthew Ziegelmann, Landon Trost, Rochester, MN INTRODUCTION AND OBJECTIVES: Inflatable penile prosthesis (IPP) remains the gold standard for refractory erectile dysfunction (ED). Despite ongoing improvements, infectious complications remain a significant concern in IPP revision surgery. We therefore sought to evaluate the impact of number of IPPs and IPP surgeries on subsequent infection rates.
METHODS: A retrospective analysis was performed of all men presenting to a tertiary referral center for consideration of IPP revision or salvage surgery between 2013 & 2015. Demographic and clinical features were reviewed, including number of prior IPPs, reason for evaluation, and rate, number, and timing of IPP infections. Statistical analyses were performed to evaluate associations between number of IPP related surgeries and device placements and resultant infectious complications.
RESULTS: A total of 44 men (median age 69; range 50, 88) were identified with at least one prior IPP. The most common reason for presentation was malfunction (52%, 23/44), followed by infection with device removal (23%, 10/44). Prior surgeries were performed at various facilities, representing a geographically diverse surgical cohort. Overall, the risk of subsequent device infection at revision surgery was strongly correlated and increased linearly based on the number of prior IPPs: 1 prior IPP (6.8%; 3/44), 2 prior (18.2%; 4/22), 3 prior (33.3%; 4/12), 4 prior (50%; 4/8), and 5 prior (100%; 2/2) (R 2 ¼0.90, p¼0.01). Similarly, rates of infection positively correlated with number of prior IPP-related surgeries performed (R 2 ¼0.97, p<0.01). Freedom from an episode of IPP infection decreased with Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e313
